Significant association seen for older age with increased risk for developing mastectomy skin flap\/nipple necrosis, infection, seroma<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b>
\n<\/b><\/p>\n
FRIDAY, Dec. 27, 2024 (HealthDay News) — For patients undergoing breast reconstruction after mastectomy, age impacts surgical outcomes, with older age negatively correlated with the Satisfaction with Breasts domain of the BREAST-Q, but positively correlated with Psychosocial Well-Being, according to a study published in the January issue of Plastic and Reconstructive Surgery<\/em>.<\/p>\n Minji Kim, from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a retrospective analysis of patients who underwent autologous (ABR) or implant-based breast reconstruction (IBR) after mastectomy to examine the impact of age on complications and patient-reported outcomes (PROs) measured preoperatively, at six months, and at one to five years postoperatively.<\/p>\n The study included 4,730 patients: 32.5 and 67.5 percent underwent ABR and IBR, respectively. The researchers observed a significant association for older age with an increased risk for developing mastectomy skin flap\/nipple necrosis, infection, and seroma. A negative correlation was seen for older age with the Satisfaction with Breasts domain of the BREAST-Q, while a positive correlation was seen with the Psychosocial Well-Being domain. There was no correlation observed for older age with the Physical Well-Being of the Chest or Sexual Well-Being domains. Different complications and PRO profiles were seen in subgroup analyses of ABR and IBR patients.<\/p>\n “Older patients should be informed about the potential associated risks and anticipated PROs,” the authors write. “Surgeons and patients can also use our findings to optimize older patients’ postoperative satisfaction.”<\/p>\n Authors disclosed ties to RTI Surgical, MirrorMe3D, Pfizer, Regeneron, Atyr, Integra, and PureTech.<\/p>\n